Atlas Trials

EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis

Clinical trial NCT03650712 · COMPLETED

Trial details

NCT number
NCT03650712
Sponsor
Katie Larson Ode
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cystic Fibrosis-related Diabetes
Start date
2019-07-01
Primary completion
2023-08-31
Enrollment
317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.